Evidence map›Paper›PMID 38564765›Full record

ArticleBlood advances2024

Thrombocytosis and megakaryocyte changes associated with PRCA.

Joelle Abdallah, Robert George Williams, Hussein Awada, Ganesh Raman, Yusuf Ozcan, Mark Orland, Mutlu Mete, Weina Chen, Carmelo Gurnari, Jaroslaw P Maciejewski and 1 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Joelle AbdallahDivision of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX.ORCID 0000-0002-2471-2075
Robert George WilliamsDivision of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX.
Hussein AwadaTranslational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH.
Ganesh RamanDivision of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX.
Yusuf OzcanUniversity of Texas Dallas, Dallas TX.
Mark OrlandTranslational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH.ORCID 0000-0002-1842-6187
Mutlu MeteDepartment of Computer Science, Texas A&M University-Commerce, Commerce, TX.
Weina ChenDepartment of Pathology, UT Southwestern Medical Center, Dallas, TX.ORCID 0000-0001-5638-4371
Carmelo GurnariTranslational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH.ORCID 0000-0001-6829-5544
Jaroslaw P MaciejewskiTranslational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH.
Taha BatDivision of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX.ORCID 0000-0002-9879-3402
Southwestern Medical CenterCleveland Clinic · USEast Texas A&M University · USUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MegakaryocytesThrombocytosisHumansMyeloproliferative Disorders

Identifiers

PMID38564765
PMCPMC11215193
OpenAlexW4393573659

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.